Pfizer studying new pill in hopes it'll help with mild COVID symptoms
Pfizer is launching a large clinical study for a new pill that it hopes could prevent worse symptoms for patients with mild COVID-19.
The first participant has now been dosed in this "pivotal Phase 2/3 clinical trial," Pfizer said.
Drugs like Remdesivir and Dexamethasone can help people recover faster, but those are only reserved for people who are extremely ill and in the hospital.
If proven effective, Pfizer will ask the FDA for authorization.
-ABC News' Sony Salzman